Radiofrequency (rf) Safety Considerations For Wireless Cardiotocography (ctg) Monitoring Systems (dsi/2026/012)

Reason
The MHRA has conducted a review into the use of wireless cardiotocography (CTG) systems that use radiofrequency (RF) telemetry channels. Signal crossover, erroneous CTG traces and signal dropouts have been identified as patient safety risks associated with these devices.
Classification
Unclassified
Category
drug recall
Country
United Kingdom
Agency
UK Medicines and Healthcare products Regulatory Agency
Recall date
2026-09-17
Status
Ongoing
Distribution
United Kingdom

Official recall notice from UK Medicines and Healthcare products Regulatory Agency

Recall details on Nibble Recalls: https://trynibble.app/recalls/67edbaea-d2c1-4d1b-a342-b54c01a85d42